Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-Q for the period ended Sep 30, 2017

Filed with the SEC on Nov 14, 2017 and accepted by EDGAR at Nov 14, 2017, 20:53 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Operating income3 months2017-07-01 to 2017-09-30−$893.8kus-gaap:OperatingIncomeLoss
Operating income9 months2017-01-01 to 2017-09-30−$1.9mus-gaap:OperatingIncomeLoss
Net income3 months2017-07-01 to 2017-09-30−$1.4mus-gaap:NetIncomeLoss
Net income9 months2017-01-01 to 2017-09-30−$3.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2017-07-01 to 2017-09-30−$0.18us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2017-01-01 to 2017-09-30−$0.41us-gaap:EarningsPerShareBasicAndDiluted
Current assetsAt period end2017-09-30$77.2kus-gaap:AssetsCurrent
Total assetsAt period end2017-09-30$267.8kus-gaap:Assets
Current liabilitiesAt period end2017-09-30$3.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-09-30$3.8mus-gaap:Liabilities
Short-term borrowingsAt period end2017-09-30$204.1kus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2017-09-30−$3.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001213900-17-012064. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.